Search results

The COVID-19 pandemic was unprecedented and has disproportionately affected the lives and livelihoods of people worldwide. Many governments restricted social and economic activities to curb the virus, and with the availability of the COVID-19 vaccine, many see it as providing hope to return to normalcy. Within such a context, China, Russia, and the United States (USA) have leveraged their vaccine diplomacy to gain and expand their influence. Vaccine diplomacy could help major powers cement their influence well beyond the pandemic if successfully deployed. By examining the vaccine diplomacy race in Southeast Asia, this chapter reveals the factors that motivate major powers to engage in the race and the strategies used. This chapter also assesses China’s vaccine diplomacy in Malaysia and how it has contributed to cementing a stronger bilateral relationship between Malaysia and China that would probably outlast the pandemic.

The initial policy of the countries that developed vaccines has been to lock the vaccine by patent. This has been due to the fact that domestic demand for vaccine was mounting. Since only a few countries could invest in it, manufacturing and export remained at the behest of those few resulting in deep inequity in the global rollout. Pandemics are global health crises. Hence, calls for the patent waiver for the COVID-19 vaccine are growing to access the vaccine. The vaccine and its production, marketing and distribution have been politicized driven by the hegemonic aspiration. Both manufacturing and import-dependent countries are racing to win the diplomatic battle: the former has to win to gain hegemony and the latter to get the vaccine. Hence, the vaccine distribution has been marked with deep discrimination, and as a result, the migrant community is less likely to get their vaccine on time. This article engages in the decades-long debate over intellectual property rights and patenting life-saving vaccines. We argue that exemption of COVID-19 vaccines from intellectual property rights would improve global access and equity.

This chapter seeks to look at the most important trends in international relations and global affairs spurred by the coronavirus crisis, and its long-term repercussions. In this analysis the author adapts the current biopolitical scholarship to such disciplines as security studies, foreign policy analysis, international relations and regional studies, and world politics and globalization. The chapter starts with discussing the biopolitics of the coronavirus crisis from a security perspective that requires a juxtaposition of COVID-19 emergency with some other securitized biopolitical events and experiences such as the war on terror and the refugee crisis. When it comes to the global level, the analysis includes the new roles of global organizations and their contribution to the fight against COVID-19. Another perspective is grounded in the discussions on the idea of “the international” and the reverberations of COVID-19 for the entire system of inter-state/inter-governmental/trans-national relations, including its regional dimensions. From the viewpoint of national foreign policies, the pandemic can be viewed as a global calamity producing new forms of diplomatic activity that significantly re-actualize and expand the concepts of biodiplomacy and health diplomacy.

The COVID-19 pandemic and its related economic meltdown and social unrest severely challenged most countries, their societies, economies, organizations, and individual citizens. Focusing on both more and less successful country-specific initiatives to fight the pandemic and its multitude of related consequences, this chapter explores implications for leadership and effective action at the individual, organizational, and societal levels. As international management scholars and consultants, the authors document actions taken and their wide-ranging consequences in a diverse set of countries, including countries that have been more or less successful in fighting the pandemic, are geographically larger and smaller, are located in each region of the world, are economically advanced and economically developing, and that chose unique strategies versus strategies more similar to those of their neighbors. Cultural influences on leadership, strategy, and outcomes are described for 19 countries. Informed by a cross-cultural lens, the authors explore such urgent questions as: What is most important for leaders, scholars, and organizations to learn from critical, life-threatening, society-encompassing crises and grand challenges? How do leaders build and maintain trust? What types of communication are most effective at various stages of a crisis? How can we accelerate learning processes globally? How does cultural resilience emerge within rapidly changing environments of fear, shifting cultural norms, and profound challenges to core identity and meaning? This chapter invites readers and authors alike to learn from each other and to begin to discover novel and more successful approaches to tackling grand challenges. It is not definitive; we are all still learning.

This paper analyses the escalating Sino-Western race to develop a safe, efficacious and durable vaccine (i.e. “Goldilocks COVID-19 vaccine”). It argues that such efforts would be considerably more effective if there is greater international cooperation instead of the corrosive rivalry driven by misplaced nationalism.

This study deploys a case-study approach, supported by literature on existing coronavirus disease 2019 (COVID-19) vaccine development efforts.

Despite the seeming success of recent COVID-19 vaccines, their actual efficacy is far from certain. Moreover, access to these vaccines would not be equitable internationally. This problem is exacerbated by the fact that their unique properties make storage and distribution prohibitively expensive, and international mechanisms to provide distribution to economically depressed regions are non-existent. Given the significant difficulties, it would be incumbent upon the great powers (i.e. China and America) to work together not only in vaccine development but also in the establishment of a distribution platform to ensure equitable access worldwide.

This study is one of the few social science research papers on COVID-19 vaccine development and its implications for society at large.

This study has aimed to analyse the role of innovation-sharing collaboration in the large-scale manufacturing of Covid-19 vaccination across the globe and its impact on the mortality rate of the countries where the pharmaceutical manufacturers received such innovation.

The authors have relied upon the difference-in-difference (DID) approach by utilizing the data available on public platforms such as World Health Organization (WHO) databank, organization for economic co-operation and development (OECD) data bank, istat, Indian bureau of statistics and European centre for disease prevention and control (ecdc) from 2020 to 2021 to establish the empirical inference of the analysis.

This study’s results present that after the invention and commercialization of the vaccine, the Covid-19 impact was still intact and people were dying continuously. However, it was impossible to fulfil the demand of the 7 billion population in a short time. In the light of these facts, the WHO encouraged sharing vaccine innovation with other countries to enhance production capacity. The authors found that after vaccine innovation sharing, Covid-19’s devastation slowed: the fatality rate was marginally reduced, and economic conditions started their recovery journey.

This study’s findings present that the Covid-19 vaccine played a pivotal role in tackling the Covid-19’s devastating impact on the entire world. It emphasizes the role of innovation-sharing collaborations in curtailing hazardous consequences, including the mortality rate during a crisis, and such collaborations’ impact on the countries where institutions involved in them reside.